A non-invasive, AI-based, wearable earpiece that continuously monitors brain activity to enable the early detection...
November 2025
This designation marks a significant milestone for patients and reaffirms Kedrion’s commitment to addressing unmet...
SHANGHAI and NANJING, China and PLEASANTON, Calif., Nov. 27, 2025 /PRNewswire/ — IASO Biotechnology (“IASO Bio”),...
YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ — GC Genome, a leading clinical genomics and...
New addition strengthens SK Biopharmaceuticals’ radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global...
MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ — Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF)...
MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ — Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF)...
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to...
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to...
DÜSSELDORF, Allemagne, 26 novembre 2025 /PRNewswire/ — mAIbe et LenioBio ont le plaisir d’annoncer une...




